CAM2602 is an orally active Aurora A-TPX2 protein-protein interaction inhibitor with a human Kd of 19 nM for Aurora A. CAM2602 increases the proportion of PH3 positive cells while reducing P-T288 Aurora A levels. CAM2602 arrests tumor xenograft growth in mice. CAM2602 can be used for the research of cancer, such as acute T cell leukemia[1].
Molekulargewicht:
484.96
Reinheit:
99.85
CAS Nummer:
[3056388-47-4]
Formel:
C23H21ClN4O4S
Target-Kategorie:
Aurora Kinase
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten